Joseph EdelmanIMVT history

Issuer:
IMMUNOVANT INC
Quarters tracked:
18 (Q2 2020Q1 2026)
Current shares:
1,597,383
Current value:
$39.68M
Peak shares:
3,814,691 (Q3 2023)
Overall change:
+45%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 20261,597,383$39.68M$24.84-397,507-20%
Q4 20251,994,890$50.71M$25.42+407,000+26%
Q3 20251,587,890$25.60M$16.12-550,000-26%
Q2 20252,137,890$34.21M$16.00-706,182-25%
Q1 20252,844,072$48.60M$17.09+704,873+33%
Q4 20242,139,199$52.99M$24.77-239,563-10%
Q3 20242,378,762$67.82M$28.51+454,976+24%
Q2 20241,923,786$50.79M$26.40-1,039,426-35%
Q1 20242,963,212$95.74M$32.31+635,130+27%
Q4 20232,328,082$98.08M$42.13-1,486,609-39%
Q3 20233,814,691$146.45M$38.39+1,290,908+51%
Q2 20232,523,783$47.88M$18.97+1,231,925+95%
Q1 20231,291,858$20.04M$15.51+1,141,858+761%
Q4 2022150,000$2.66M$17.75+150,000+100%
Q1 2021SOLD-1,400,000-100%
Q4 20201,400,000$64.67M$46.1900%
Q3 20201,400,000$49.27M$35.19+300,000+27%
Q2 20201,100,000$26.79M$24.35NEW